SEC Form EFFECT filed by Navidea Biopharmaceuticals Inc.
$NAVB
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Health Care
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | January 31, 2024 |
| Accession Number: | 0001437749-24-002308 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||